Targeted Protein Degradation Market

The Targeted Protein Degradation (TPD) market involves developing novel therapeutics capable of eliminating disease-causing proteins. Key customers include pharmaceutical and biotechnology companies who are investing heavily in this area for drug development. The market's primary growth is driven by advances in precision medicine and the unique ability of TPD technology to target proteins previously considered 'undruggable', opening new treatment avenues for complex diseases.